Literature DB >> 15670166

An NMR study of the interaction between the human copper(I) chaperone and the second and fifth metal-binding domains of the Menkes protein.

Lucia Banci1, Ivano Bertini, Simone Ciofi-Baffoni, Christos T Chasapis, Nick Hadjiliadis, Antonio Rosato.   

Abstract

The interaction between the human copper(I) chaperone, HAH1, and one of its two physiological partners, the Menkes disease protein (ATP7A), was investigated in solution using heteronuclear NMR. The study was carried out through titrations involving HAH1 and either the second or the fifth soluble domains of ATP7A (MNK2 and MNK5, respectively), in the presence of copper(I). The copper-transfer properties of MNK2 and MNK5 are similar, and differ significantly from those previously observed for the yeast homologous system. In particular, no stable adduct is formed between either of the MNK domains and HAH1. The copper(I) transfer reaction is slow on the time scale of the NMR chemical shift, and the equilibrium is significantly shifted towards the formation of copper(I)-MNK2/MNK5. The solution structures of both apo- and copper(I)-MNK5, which were not available, are also reported. The results are discussed in comparison with the data available in the literature for the interaction between HAH1 and its partners from other spectroscopic techniques.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15670166     DOI: 10.1111/j.1742-4658.2004.04526.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  17 in total

1.  Metal binding domains 3 and 4 of the Wilson disease protein: solution structure and interaction with the copper(I) chaperone HAH1.

Authors:  Lucia Banci; Ivano Bertini; Francesca Cantini; Amy C Rosenzweig; Liliya A Yatsunyk
Journal:  Biochemistry       Date:  2008-06-18       Impact factor: 3.162

Review 2.  Structural biology of copper trafficking.

Authors:  Amie K Boal; Amy C Rosenzweig
Journal:  Chem Rev       Date:  2009-10       Impact factor: 60.622

3.  The architecture of CopA from Archeaoglobus fulgidus studied by cryo-electron microscopy and computational docking.

Authors:  Gregory S Allen; Chen-Chou Wu; Tim Cardozo; David L Stokes
Journal:  Structure       Date:  2011-08-04       Impact factor: 5.006

4.  Structure of human Wilson protein domains 5 and 6 and their interplay with domain 4 and the copper chaperone HAH1 in copper uptake.

Authors:  David Achila; Lucia Banci; Ivano Bertini; Jennifer Bunce; Simone Ciofi-Baffoni; David L Huffman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-29       Impact factor: 11.205

Review 5.  Cellular copper distribution: a mechanistic systems biology approach.

Authors:  Lucia Banci; Ivano Bertini; Francesca Cantini; Simone Ciofi-Baffoni
Journal:  Cell Mol Life Sci       Date:  2010-03-24       Impact factor: 9.261

Review 6.  Molecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypes.

Authors:  P de Bie; P Muller; C Wijmenga; L W J Klomp
Journal:  J Med Genet       Date:  2007-08-23       Impact factor: 6.318

7.  Multiple metal binding domains enhance the Zn(II) selectivity of the divalent metal ion transporter AztA.

Authors:  Tong Liu; Hermes Reyes-Caballero; Chenxi Li; Robert A Scott; David P Giedroc
Journal:  Biochemistry       Date:  2007-09-08       Impact factor: 3.162

8.  An NMR study of the interaction of the N-terminal cytoplasmic tail of the Wilson disease protein with copper(I)-HAH1.

Authors:  Lucia Banci; Ivano Bertini; Francesca Cantini; Chiara Massagni; Manuele Migliardi; Antonio Rosato
Journal:  J Biol Chem       Date:  2009-01-30       Impact factor: 5.157

9.  Copper trafficking in biology: an NMR approach.

Authors:  Lucia Banci; Ivano Bertini; Simone Ciofi-Baffoni
Journal:  HFSP J       Date:  2009-03-18

Review 10.  Biochemical basis of regulation of human copper-transporting ATPases.

Authors:  Svetlana Lutsenko; Erik S LeShane; Ujwal Shinde
Journal:  Arch Biochem Biophys       Date:  2007-05-02       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.